Literature DB >> 25895971

The Granuloma Response Controlling Cryptococcosis in Mice Depends on the Sphingosine Kinase 1-Sphingosine 1-Phosphate Pathway.

Amir M Farnoud1, Arielle M Bryan1, Talar Kechichian2, Chiara Luberto3, Maurizio Del Poeta4.   

Abstract

Cryptococcus neoformans is a fungal pathogen that causes pulmonary infections, which may progress into life-threatening meningitis. In commonly used mouse models of C. neoformans infections, fungal cells are not contained in the lungs, resulting in dissemination to the brain. We have previously reported the generation of an engineered C. neoformans strain (C. neoformans Δgcs1) which can be contained in lung granulomas in the mouse model and have shown that granuloma formation is dependent upon the enzyme sphingosine kinase 1 (SK1) and its product, sphingosine 1-phosphate (S1P). In this study, we have used four mouse models, CBA/J and C57BL6/J (both immunocompetent), Tgε26 (an isogenic strain of strain CBA/J lacking T and NK cells), and SK(-/-) (an isogenic strain of strain C57BL6/J lacking SK1), to investigate how the granulomatous response and SK1-S1P pathway are interrelated during C. neoformans infections. S1P and monocyte chemotactic protein-1 (MCP-1) levels were significantly elevated in the bronchoalveolar lavage fluid of all mice infected with C. neoformans Δgcs1 but not in mice infected with the C. neoformans wild type. SK1(-/-) mice did not show elevated levels of S1P or MCP-1. Primary neutrophils isolated from SK1(-/-) mice showed impaired antifungal activity that could be restored by the addition of extracellular S1P. In addition, high levels of tumor necrosis factor alpha were found in the mice infected with C. neoformans Δgcs1 in comparison to the levels found in mice infected with the C. neoformans wild type, and their levels were also dependent on the SK1-S1P pathway. Taken together, these results suggest that the SK1-S1P pathway promotes host defense against C. neoformans infections by regulating cytokine levels, promoting extracellular killing by phagocytes, and generating a granulomatous response.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25895971      PMCID: PMC4468535          DOI: 10.1128/IAI.00056-15

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  53 in total

Review 1.  Sphingosine 1-phosphate and its receptors: an autocrine and paracrine network.

Authors:  Hugh Rosen; Edward J Goetzl
Journal:  Nat Rev Immunol       Date:  2005-07       Impact factor: 53.106

2.  Does sphingosine 1-phosphate play a protective role in the course of pulmonary tuberculosis?

Authors:  Sanjay K Garg; Marilina B Santucci; Miriam Panitti; Leo Pucillo; Marialuisa Bocchino; Fumikazu Okajima; Prakash S Bisen; Cesare Saltini; Maurizio Fraziano
Journal:  Clin Immunol       Date:  2006-10-16       Impact factor: 3.969

3.  Methylation of glycosylated sphingolipid modulates membrane lipid topography and pathogenicity of Cryptococcus neoformans.

Authors:  Arpita Singh; Haitao Wang; Liana C Silva; Chongzheng Na; Manuel Prieto; Anthony H Futerman; Chiara Luberto; Maurizio Del Poeta
Journal:  Cell Microbiol       Date:  2012-01-09       Impact factor: 3.715

4.  Role of sphingosine-1-phosphate (S1P) and S1P receptor 2 in the phagocytosis of Cryptococcus neoformans by alveolar macrophages.

Authors:  Travis McQuiston; Chiara Luberto; Maurizio Del Poeta
Journal:  Microbiology (Reading)       Date:  2011-02-03       Impact factor: 2.777

5.  TNF regulates chemokine induction essential for cell recruitment, granuloma formation, and clearance of mycobacterial infection.

Authors:  Daniel R Roach; Andrew G D Bean; Caroline Demangel; Malcolm P France; Helen Briscoe; Warwick J Britton
Journal:  J Immunol       Date:  2002-05-01       Impact factor: 5.422

6.  Cryptococcal urease promotes the accumulation of immature dendritic cells and a non-protective T2 immune response within the lung.

Authors:  John J Osterholzer; Rishi Surana; Jami E Milam; Gerald T Montano; Gwo-Hsiao Chen; Joanne Sonstein; Jeffrey L Curtis; Gary B Huffnagle; Galen B Toews; Michal A Olszewski
Journal:  Am J Pathol       Date:  2009-02-13       Impact factor: 4.307

7.  Finding a way out: lymphocyte egress from lymphoid organs.

Authors:  Susan R Schwab; Jason G Cyster
Journal:  Nat Immunol       Date:  2007-12       Impact factor: 25.606

Review 8.  Sphingosine-1-phosphate receptor 2.

Authors:  Mohamad Adada; Daniel Canals; Yusuf A Hannun; Lina M Obeid
Journal:  FEBS J       Date:  2013-08-19       Impact factor: 5.542

9.  Cryptococcus neoformans modulates extracellular killing by neutrophils.

Authors:  Asfia Qureshi; Angus Grey; Kristie L Rose; Kevin L Schey; Maurizio Del Poeta
Journal:  Front Microbiol       Date:  2011-09-21       Impact factor: 5.640

10.  Insights into the mechanisms of protective immunity against Cryptococcus neoformans infection using a mouse model of pulmonary cryptococcosis.

Authors:  Karen L Wozniak; Sailatha Ravi; Sandra Macias; Mattie L Young; Michal A Olszewski; Chad Steele; Floyd L Wormley
Journal:  PLoS One       Date:  2009-09-03       Impact factor: 3.240

View more
  14 in total

1.  Analysis of sphingolipids, sterols, and phospholipids in human pathogenic Cryptococcus strains.

Authors:  Ashutosh Singh; Andrew MacKenzie; Geoffrey Girnun; Maurizio Del Poeta
Journal:  J Lipid Res       Date:  2017-08-15       Impact factor: 5.922

Review 2.  Sphingosine-1-phosphate receptors and innate immunity.

Authors:  Arielle M Bryan; Maurizio Del Poeta
Journal:  Cell Microbiol       Date:  2018-03-23       Impact factor: 3.715

Review 3.  Sphingolipids in neutrophil function and inflammatory responses: Mechanisms and implications for intestinal immunity and inflammation in ulcerative colitis.

Authors:  Mel Pilar Espaillat; Richard R Kew; Lina M Obeid
Journal:  Adv Biol Regul       Date:  2016-11-14

4.  An Immunogenic and Slow-Growing Cryptococcal Strain Induces a Chronic Granulomatous Infection in Murine Lungs.

Authors:  Calla L Telzrow; Shannon Esher Righi; Natalia Castro-Lopez; Althea Campuzano; Jacob T Brooks; John M Carney; Floyd L Wormley; J Andrew Alspaugh
Journal:  Infect Immun       Date:  2022-05-19       Impact factor: 3.609

Review 5.  Sphingolipids as targets for treatment of fungal infections.

Authors:  Rodrigo Rollin-Pinheiro; Ashutosh Singh; Eliana Barreto-Bergter; Maurizio Del Poeta
Journal:  Future Med Chem       Date:  2016-08-09       Impact factor: 3.808

Review 6.  Sphingolipids as Regulators of the Phagocytic Response to Fungal Infections.

Authors:  Arielle M Bryan; Maurizio Del Poeta; Chiara Luberto
Journal:  Mediators Inflamm       Date:  2015-11-25       Impact factor: 4.711

Review 7.  Mechanisms of Pulmonary Escape and Dissemination by Cryptococcus neoformans.

Authors:  Steven T Denham; Jessica C S Brown
Journal:  J Fungi (Basel)       Date:  2018-02-17

Review 8.  An insight into new strategies to combat antifungal drug resistance.

Authors:  Yan-Hua Zheng; Yue-Yun Ma; Yi Ding; Xie-Qun Chen; Guang-Xun Gao
Journal:  Drug Des Devel Ther       Date:  2018-11-05       Impact factor: 4.162

9.  FTY720 reactivates cryptococcal granulomas in mice through S1P receptor 3 on macrophages.

Authors:  Arielle M Bryan; Jeehyun Karen You; Travis McQuiston; Cristina Lazzarini; Zhijuan Qiu; Brian Sheridan; Barbara Nuesslein-Hildesheim; Maurizio Del Poeta
Journal:  J Clin Invest       Date:  2020-09-01       Impact factor: 14.808

10.  Activation-Induced Cell Death of Dendritic Cells Is Dependent on Sphingosine Kinase 1.

Authors:  Anja Schwiebs; Olga Friesen; Elisabeth Katzy; Nerea Ferreirós; Josef M Pfeilschifter; Heinfried H Radeke
Journal:  Front Pharmacol       Date:  2016-04-15       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.